[1LBA-145] DDrare: Database of Drug Development for Rare Diseases and Its Data Analysis - Multiple Drugs Tested in a Clinical Trial -

〇Ryuichi Sakate¹, Akiko Fukagawa¹, Kenji Mizuguchi¹, Makoto Hirata¹, Hideyuki Kagii², Takayuki Sasaki², Mariko Hirozane², Masami Morita² (1.National Institutes of Biomedical Innovation, Health and Nutrition, 2.Office of Pharmaceutical Industry Research)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1LBA-146] Acquirement of anti-idiotype DNA aptamers for therapeutic monoclonal antibody Pertuzumab and Rituximab and its application to high-throughput bioanalysis

〇Tomohiro Yamada¹, Taro Yamada², Yutaka Shimizu², Hajime Mizuno¹, Kaori Tsukakoshi², Toshimasa Toyo'oka¹, Kazunori Ikebukuro², Kenichiro Todoroki¹ (1.Dept of Anal and Bio-Anal Chem, Univ of Shizuoka, 2.Dept of Biot and Life Sci, Tokyo Univ of Agri and Tech)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1LBA-147] Molecular and serological surveillance for Bluetongue virus in Zambia

〇Herman Moses Chambaro¹, Sasaki Michihito¹, Edgar Simulundu², Kombe Isaac², Yona Sinkala⁴, Alikhadio Maseko⁴, Choopa Chimvwele⁴, Paul Fandamu⁴, David Squarre⁵, Musso Munyeme^2,3, Harima Hayato^6,7, Martin Simuunza^2,3, Aaron s Mweene^2,3, Eshita Yuki⁶, Mudenda B Hang’ombe^3,8, Orba Yasuko¹, Sawa Hirofumi^1,9,10 (1.Div of Mol Pathbio, Res Cent. for Zoon Cont, Hokkaido Uni., 2.Dis Cont Dept, Sch of Vet Med, Uni of Zambia, 3.Africa Cent of Exce for Inf Dis of Humans and Animals, Uni of Zambia, 4.Mini of Fish and Liv, Zambia, 5.Dept of Nat Parks and Wildlife, Zambia, 6.Cent for Zoon Cont, Hokkaido Uni, Japan, 7.Hokudai Cent for Zoon Cont in Zambia, 8.Paraclinical stud Dept, Sch of Vet Med, Uni of Zambia, 9.Global Insti for Collaborative Res and Education (GI-CoRE), Hokkaido Uni,, 10.Global Vir Net, Baltimore, Maryland, USA)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1LBA-148] Development of highly sensitive pCAGGS-EGFP reporter assays for measuring exon skipping efficiency in vitro and in vivo

〇Yuko Hara¹, Yukiko Inoue-Ueno², Tetsuya Nagata³, Yoshitaka Mizobe¹, Hotake Takizawa¹, Yoshiaki Masaki⁴, Kohji Seio⁴, Takayoshi Inoue², Shin'ichi Takeda¹, Yoshitsugu Aoki¹ (1.Dept of Mol. Thr.,NIN,NCNP, 2.Dept of Biochem. and Cell Biol.,NIN.,NCNP, 3.Dept of Neurol. and Neurol.Sci,TMDU, 4.School of Life Science and Technology, Tokyo Tech)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1LBA-149] Establishment of gene transfer methods in the Drosophila embryos and the larval brain by electroporation.

〇Tomoya Tanaka¹, Rikako Sanuki¹ (1.Department of Applied Biology, Kyoto Institute of Technology)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1LBA-150] Ultra high-throughput transcriptome analysis using Quartz-Seq2

〇Yohei Sasagawa¹, Kaori Tanaka¹, Itoshi Nikaido¹ (1.Laboratory for Bioinformatics Research, RIKEN Center for Biosystems Dynamics Research)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1LBA-151] Macromolecular delivery in the cell by the shock wave irradiation

〇Shunsuke Suzuki¹, Mieko Kogi¹, Takumi Kobayashi², Kouji Aizawa¹, Teruhide Yamaguchi¹ (1.Kanazawa Institute of Technology, Institute of Advanced Medical and Engineering Technology for Aging, 2.Kanazawa Institute of Technology)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1LBA-152] Cryo-EM imaging of Kv channel with membrane potential applied

〇Hideki Shigematsu^1,2, Youshan Yang², Yanyang Yang², Fred Sigworth² (1.RIKEN SPring-8 Center, 2.CMP, Yale University)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1LBA-153] Biosafety for field use of GMM: a biological containment strategy based on phosphite dependency

〇Kei Motomura^1,2, Zen-ichiro Katsuura¹, Kosuke Sano¹, Satoru Watanabe^2,3, Akio Kuroda^1,2, Ryuichi Hirota^1,2 (1.Dept. Mol. Biotech., Grad. Sch. AdSM, Hiroshima Univ., 2.JST-ALCA, 3.Dept. Biosci., Tokyo Univ. Agric.)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1LBA-154] Increasing robustness of the biocontainment strategy by introducing a safeguarding system based on the mutation mechanism of escape mutants

〇Zen-ichiro Katsuura¹, Kei Motomura^1,2, Akio Kuroda^1,2, Ryuichi Hirota^1,2 (1.Dept. Mol. Biotech., Grad. Sch. AdSM, Hiroshima Univ., 2.JST-ALCA)

The 41st Annual Meeting of the Molecular Biology Society of Japan